Li Z et al., 2020-12: US study showing methylene blue inhibits Zika and dengue protease NS2B-NS3 activity, protects 3D mini-brain organoids from Zika infection, and reduces viremia in mice , with no light requirement.
Here, we demonstrate that methylene blue, an FDA-approved drug, is a broad-spectrum and potent antiviral against Zika virus and Dengue virus both in vitro and in vivo.
Abstract
Li Z et al., 2020-12: US study showing methylene blue inhibits Zika and dengue protease NS2B-NS3 activity, protects 3D mini-brain organoids from Zika infection, and reduces viremia in mice , with no light requirement. Study type: in vitro plus animal (mouse viremia model; 3D human mini-brain organoids); no patients. Country: USA (NIH NCATS, Wadsworth Center, et al.). Mechanism: inhibition of NS3 protease and its NS2B co-factor interaction. Funding: NIAID R21 AI133219, R21 AI140491, R21 AI134568, R56 AI131669, R01 AI131669. Competing interests: 'No potential conflict of interest was reported by the author(s).' Comparator: vehicle-treated infected cells/animals. Study type: lab.
